New, more maneuverable unit joins competitors in better designed, mobile x-ray.
Carestream now has U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System.
Carestream put the mobile x-ray front and center at RSNA 2011, but now can take orders in the US.
The unit touts a wireless detector that can be used in other Carestream unites in a hospital to improve efficiency.
It also hosts software meant to help a radiographer quickly and accurately align the top tube with a grid for better image quality.
The top column is collapsible and a dual-drive systems enables the unit to make tight turns without strain on staff. The DRX-Revolution also offers a long tube head reach, so radiographers can conduct X-ray exams in crowded spots.
It will compete with other entries in the mobile x-ray market, such as Siemens Mobilett Mira Mobile Digital X-Ray System.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.